Using the Kaplan–Meier actuarial analysis, we demonstrated that the time to first tumor relapse was lower for the patients with a high PD-L1 status of luminal primary cancer in comparison with less aggressive low PD-L1 expressing luminal NMIBC (Figure 5). This evidence concerns the gene CD274 and cancer.